In the study of "Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial" by Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R., posted in US National Library of Medicine National Institutes of Health, found that daily 5 mg of vitamin K1 supplementation for 2 to 4 y does not protect against age-related decline in BMD, but may protect against fractures and cancers in postmenopausal women with osteopenia. More studies are needed to further examine the effect of vitamin K on fractures and cancers.
Thursday, December 8, 2011
Vitamin K and Osteopenia
Posted by Chantel M. Contributed by US National Library of Medicine National Institutes of Health
In the study of "Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial" by Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R., posted in US National Library of Medicine National Institutes of Health, found that daily 5 mg of vitamin K1 supplementation for 2 to 4 y does not protect against age-related decline in BMD, but may protect against fractures and cancers in postmenopausal women with osteopenia. More studies are needed to further examine the effect of vitamin K on fractures and cancers.
In the study of "Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial" by Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R., posted in US National Library of Medicine National Institutes of Health, found that daily 5 mg of vitamin K1 supplementation for 2 to 4 y does not protect against age-related decline in BMD, but may protect against fractures and cancers in postmenopausal women with osteopenia. More studies are needed to further examine the effect of vitamin K on fractures and cancers.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment